Arthritis as a risk factor for incident coronary heart disease in elderly Japanese-American males: the Honolulu Heart Program.
Background: Arthritis is the most common chronic disease in the
elderly. Studies show that rheumatoid arthritis is a risk factor for
cardiovascular morbidity and mortality, and osteoarthritis is associated
with an unfavorable cardiovascular risk factor profile.
Methods: At the Honolulu Heart Program's fourth examination in 1991 to 1993, arthritis status was assessed among a cohort of 3741 Japanese-American males, ages 71 to 93 years. Arthritis was determined by self-report of physician diagnosis, and subjects were divided into two groups: current arthritis and no current arthritis. Eight years of follow-up data are available for incident coronary heart disease (CHD) in 2777 subjects free of CHD at baseline. Age-adjusted rates of incident CHD and means of cardiovascular risk factors were compared in each group. Cox proportional hazards models were used to calculate relative risks, adjusting for common cardiovascular risk factors, alcohol, and use of aspirin or NSAIDs, or both.
Results: There were 279 cases of incident CHD in the cohort over 8 years; in those with arthritis, 11.7% developed incident CHD, compared to 9.8% in those without arthritis (p = 0.24). Age-adjusted rates of incident CHD in those with and without arthritis were 20.5 and 18.0 per 1000 person-years, respectively (p = 0.25). Arthritis was not significantly associated with CHD risk factors. Arthritis was not a significant independent predictor of incident CHD (relative risk, 1.06; 95% CI, 0.74 to 1.51).
Conclusions: Arthritis, and most probably osteoarthritis, may not be associated with most CHD risk factors or 8-year incident CHD in elderly Japanese-American males.
Osteoarthritis (Risk factors)
Coronary heart disease (Research)
Coronary heart disease (Risk factors)
Rheumatoid arthritis (Research)
Rheumatoid arthritis (Risk factors)
Chronic diseases (Research)
Chronic diseases (Risk factors)
Masaki, Kamal H.
Rodriguez, Beatriz L.
Blanchette, Patricia L.
Pillinger, Michael H.
Curb, J. David
|Publication:||Name: Bulletin of the NYU Hospital for Joint Diseases Publisher: J. Michael Ryan Publishing Co. Audience: Academic Format: Magazine/Journal Subject: Health Copyright: COPYRIGHT 2009 J. Michael Ryan Publishing Co. ISSN: 1936-9719|
|Issue:||Date: April, 2009 Source Volume: 67 Source Issue: 2|
|Topic:||Event Code: 310 Science & research|
|Product:||Product Code: 8000200 Medical Research; 9105220 Health Research Programs; 8000240 Epilepsy & Muscle Disease R&D; 2834222 Aspirin; 2834225 Aspirin Combinations NAICS Code: 54171 Research and Development in the Physical, Engineering, and Life Sciences; 92312 Administration of Public Health Programs; 325412 Pharmaceutical Preparation Manufacturing SIC Code: 2833 Medicinals and botanicals; 2834 Pharmaceutical preparations|
Arthritis is one of the most prevalent diseases in the elderly
population, and the most frequent cause of disability in the United
States. (1,2) Several studies suggest rheumatoid arthritis (RA)
increases the risk of coronary heart disease (CHD) and CHD-related
death. (3-9) Osteoarthritis (OA), the most common joint disease in the
United States and globally, (10) has also been associated with an
unfavorable cardiovascular risk profile. In addition, studies suggest
patients with OA may be at increased risk of developing CHD. (11-14)
However, studies also suggest this risk is higher in patients with RA
than OA. There are few published data on arthritis as an independent
risk factor for incident CHD. The objective of our study was to assess
the relationship of self-reported arthritis status and incident CHD in a
large cohort of elderly Japanese-American males who were part of the
Honolulu Heart Program longitudinal cohort.
Materials and Methods
The Honolulu Heart Program is a long-term prospective epidemiological study of cardiovascular disease. The original cohort consisted of 8006 Japanese-American males living on the island of Oahu, Hawaii, in 1965, who were recruited using the World War II Selective Service Registration file. Details on the selection process of this cohort were previously published by Worth and Kagan in 1970. (15) Eligible males were born between 1900 and 1919 (ages 45 to 68 years at the first examination in 1965 to 1968). (16) The entire cohort has undergone a total of eight examinations, occurring in 1965, 1968, 1971, 1991, 1994, 1997, 1999, and 2001. This study was approved by the Institutional Review Board of Kuakini Medical Center. Procedures followed were in accordance with institutional guidelines and written informed consent was obtained from all participants.
This report is based on data obtained from the fourth examination of the cohort conducted from 1991 to 1993. At the fourth examination, 3741 males aged 71 to 93 years were assessed (80% of survivors). Of these, 1085 were ages 71 to 74; 1529 were ages 75 to 79; 707 were ages 80 to 84; and 420 were ages 85 to 93 years. Eighty-five percent of the examinations were performed at the Honolulu Heart Program clinic (n = 3192). A significant percentage of examinations were conducted at home (n = 489, or 13% of those examined) or at a nursing home (n = 60, or 1.6% of those examined). (17)
The fourth examination included demographic information, psychosocial and medical interviews, cognitive function testing, a 12-lead electrocardiogram, a pulmonary function test, anthropometry, blood pressure measurements, and fasting blood and 2-hour oral glucose tolerance tests.
Morbidity and mortality surveillance was conducted by the monitoring of hospital records from all Oahu hospitals, review of obituaries in local newspapers, the medical examiner's office, and death certificates. Medical records for all deaths and selected morbidity outcomes (including CHD) were reviewed by a trained physician panel using standardized criteria, and a final diagnosis was assigned. Data collection is believed to be essentially complete for surveillance outcomes. Attrition for this cohort is very low; at the fourth examination, only five males were lost to follow-up.
Measurement of Arthritis Status
The medical interview included questions about several diseases, including arthritis. Subjects were asked whether they had ever been hospitalized for or had a physician tell them they had arthritis. Arthritis was defined as any type of arthritis, but data are not available for specific types. Possible responses included: no arthritis, current arthritis under medical care, current arthritis not under medical care, or arthritis only in the past.
Definition of Incident Coronary Heart Disease
Incident CHD was defined as new angina pectoris, definite myocardial infarction, percutaneous transluminal catheter angioplasty or coronary artery bypass graft surgery, and CHD death or sudden death within one hour. For this report, data on incident CHD were available through December 1998 (8-year follow-up after the fourth examination).
Definition of Other Key Variables
Covariates were selected because of their potential relationship with either arthritis or with incident CHD. Body mass index (BMI) was defined as weight in kilograms divided by height in meters squared. Physical Activity Index (PAI) was based on the method used in Framingham and the Honolulu Heart Program, (18) which consists of multiplying the approximate oxygen consumption of five different levels of activity with the reported number of hours a day engaged in activity. Hypertension was defined as systolic blood pressure 140 mmHg or greater, or diastolic blood pressure 90 mmHg or greater, or taking anti-hypertensive drugs. Diabetes mellitus was defined by modified American Diabetes Association criteria (1997), as fasting glucose greater or equal to 126 mg/ dL, or 2-hour post-load glucose greater or equal to 200 mg/ dL, or taking medications (insulin or oral hypoglycemics). (19) Current smoking status and alcohol consumption (ounces per month) were determined by self-report. Use of aspirin (ASA) or an nonsteroidal anti-inflammatory drug (NS AID), or both, was determined by direct observation; participants were instructed to bring in all medications taken during the previous 2 weeks.
At the fourth examination, blood specimens were taken by venipuncture after an overnight fast of at least 12 hours. Procedures for taking and preparing blood specimens for laboratory analysis were standardized by guidelines of the lipid standardization laboratory of the Centers for Disease Control and Prevention (CDC, Atlanta, Georgia). Lipid concentrations were measured as part of the Cooperative Lipoprotein Phenotyping Study at the University of Vermont. (20) Plasma fibrinogen concentrations were measured with a clot-based end point using a BBL fibrometer (Becton-Dickinson, Baltimore, Maryland). (21)
Data on arthritis were available for 3614 subjects (97% of those examined). Those with arthritis only in the past (n = 82) and prevalent cases of CHD at the fourth examination (n = 755) were excluded, leaving 2777 subjects with current arthritis free of CHD at baseline for this analysis. Subjects were divided into two groups: those with current arthritis and those without current arthritis, as defined above. Age-adjusted means of cardiovascular risk factors were compared in those with and without current arthritis using ANOVA (analysis of variance) for continuous variables. Chi-square tests were used for categorical variables. Unadjusted and age-adjusted rates of incident CHD, expressed per 1000 person-years of follow-up, were calculated according to current arthritis status.
We assessed the association between current arthritis status and incident CHD with three separate Cox proportional hazards models. The first adjusted for age alone. The second model adjusted for age, BMI, PAI, hypertension, diabetes mellitus, HDL cholesterol, total cholesterol, and smoking status. The third model included the above variables as well as fibrinogen, alcohol use, and ASA or NSAID use, or both. Since subjects with dementia or cognitive impairment may provide unreliable information regarding medical history, Cox proportional hazards models were repeated after excluding subjects with dementia or cognitive impairment (Cognitive Abilities Screening Instrument score less than 74) (n = 425), leaving 2352 subjects for analysis. (22) All statistical analyses were done with SAS software, version 8 (SAS Institute, Cary, North Carolina).
The overall prevalence of all arthritis (current and past) in this cohort was 16.6% (600/3614), and current arthritis was 14.7% (518/3532). Age-adjusted means of cardiovascular risk factors demonstrated no significant differences between subjects with and without current arthritis, except subjects with arthritis were heavier [BMI, 23.8 (standard error, 0.155) vs. 23.3 (standard error, 0.064), p = 0.003] and more likely to use ASA or NSAIDs, or both (39.6% vs. 21.4%, p < 0.001) (Table 1). Thus, current arthritis status was not associated with most traditional cardiovascular risk factors in this cohort.
There was a total of 279 cases of incident CHD in the cohort over the 8-year follow-up period. Those with cur rent arthritis were slightly more likely to develop incident CHD over the 8-year follow-up (11.7%, 47/403), compared to those without arthritis (9.8%, 232/2374); however, this difference was not statistically significant (p = 0.24). Age-adjusted rates of incident CHD were 20.5 per 1000 person-years in those with current arthritis, compared with 18.0 in those without current arthritis (p = 0.25) (Table 2).
We used three separate Cox proportional hazards models with 8-year incident CHD as the outcome (Table 3). In the first model, the relative risk for incident CHD associated with current arthritis was 1.23 (95% CI, 0.90 to 1.68) after adjustment for age alone. In model 2, adjustment for traditional cardiovascular risk factors did not alter the relative risk (RR, 1.12; 95% CI, 0.79 to 1.58). Further adjustment for fibrinogen, alcohol use, and ASA or NSAID use, or both, did not modify this association (RR, 1.06; 95% CI, 0.74 to 1.51). The results did not change significantly when Cox models were repeated after excluding subjects with dementia or cognitive impairment (n = 425) (Table 4).
The relationship between CHD and arthritis is of significant clinical interest. Both arthritis and CHD are major causes of morbidity and mortality. These two most common forms of arthritis, RA and OA, have each been implicated as playing a role in CHD in affected patients.
In this prospective cohort study of elderly Japanese-American males, we found no significant increase in incident CHD in patients with arthritis. The lack of association persisted even after adjustment for a number of potential confounders, such as coronary risk factors and alcohol use. Overall, our cohort had a relatively low incidence of CHD, compared to other populations. In elderly Japanese-American males of the Honolulu Heart Program, the age-adjusted incidence of CHD was 20.5 per 1000 person years. A 44-year and 64-year follow-up study from the NHLBI's (National Heart, Lung, and Blood Institute) Framingham Heart Study (FHS), shows the average annual rates of a first major cardiovascular event ranging from 7/1000 in males ages 35 to 44 years to 68/1000 at ages 85 to 94. (23) In our study, participants aged 85 to 93 years had an incidence of CHD of 29 per 1000 person years follow-up, which was much lower than the incidence of CHD in the Framingham study population. The relatively low rate of CHD among our subjects may relate to either genetics or environment, as Syme and colleagues have reported a gradient of CHD mortality among Japanese males living in Japan (lowest), Hawaii (intermediate), and San Francisco (highest). (24) It is possible that our failure to observe an association between arthritis and CHD relates to the fact that we were studying a low-risk cohort for CHD. Additional studies would be needed to assess this proposition.
The Nurses' Health Study, a large prospective cohort of females, showed subjects with RA had a significantly increased risk of myocardial infarction but not stroke in comparison to those without RA.8 A large population-based cohort in Sweden followed from 1964 to 1995 revealed a higher risk of death from coronary artery disease in RA patients. (6) Other studies support RA as an independent risk factor for CHD. (3-5,7,9) In contrast to RA, the data on OA as a risk factor for CHD are less clear. Data from the Third National Health and Nutritional Examination Survey (NHANES III) (11) and other studies (12-14) indicate U.S. adults with OA have a significantly higher prevalence of cardiovascular risk factors (increased BMI, hypertension, diabetes mellitus, physical activity, lipid profile, etc.) than the non-arthritic population, which may place OA patients at risk for developing CHD. Indeed, a recent study suggests that the 10-year risk of CHD in patients with RA and OA are about equal. (25) On the other hand, some additional studies suggest that OA may not be associated with CHD. (26) Based on the available information, our data did not permit us to rigorously determine the precise arthritis diagnoses of our study patients. However, data from the Framingham and other studies suggest that the prevalence of OA and RA in the elderly population, and spondyloarthropathies in the general population are approximately 31%, 2%, and 2%, (10,27,28) respectively, indicating that most of our population may have had OA. Thus, our data suggest that OA was not a risk factor for CHD in our population. Whether this lack of association between OA and CHD is a universal phenomenon or a unique feature of our population cannot be determined from the available data set.
The etiology of any association between systemic inflammation and CHD is not well understood. Theories for the pathological association between CHD and autoimmune diseases, such as RA and systemic lupus erythematosus, include increased expression of cellular adhesion molecules, recruitment of inflammatory cells, atherogenic side effects of anti-rheumatic medications, and the lack of appropriate down-regulation of pro-inflammatory processes, leading to atherosclerosis. (29-31) OA is often classified as a non-inflammatory disease. However, osteoarthritic joints may become inflamed, and numerous studies show that inflammatory cytokines play a role in stimulating chondrocytes to increase transcription of cartilage-degrading enzymes, such as matrix metalloproteinases. (32,33) Spector and coworkers recently reported serum C-reactive protein levels are directly correlated with the risk of radiographic knee OA progression, providing evidence that inflammation may play a role in the trajectory of OA. (34) If OA does result in low-level systemic inflammation, our data suggest that, at least in our population, that inflammation was not sufficient to result in increased CHD.
One concern regarding our methodology was that, by excluding subjects with prevalent CHD, we may have been introducing bias by excluding a population that might have an altered rate of arthritis. As expected, subjects with arthritis were more likely to use an ASA or NSAID, or both. However, they did not have a higher prevalence of cardiovascular risk factors, except for a higher BMI, supporting the hypothesis that obesity predisposes to the development of OA. (35,36) The Honolulu Heart Program population is relatively lean compared to other populations in the U.S., where the average BMI is 26.6 in adult males. (37) Previous studies suggest that obesity is correlated with a lower level of physical activity and fitness, a known predictor of mortality from cardiovascular causes. (38-45) A higher level of physical fitness is associated with lower resting heart rate, blood pressure, total cholesterol, and lower rates of smoking. (41) In our population, although the BMI was slightly higher in the arthritic group, there was no correlation between arthritis and the PAI, suggesting that a higher BMI may not have limited physical activity levels in arthritic patients, in contrast to the studies mentioned above. (44,45) This may also explain the absence of a significant association between arthritis and other cardiovascular risk factors and incident CHD. Finally, although increased ASA or NSAID use among arthritis patients might have masked an increasing CHD via cardioprotective effects or, alternatively, in the case of at least some NSAIDs, might have led to an increase in CHD, (46) we observed no difference between arthritis and control groups even after adjusting for the use of these agents.
This study has several limitations. First, the study focuses on older Japanese-American males, limiting generalizability. However, previous studies from the Honolulu Heart Program have been relevant to other populations and of significant value to the advancement of science. As noted earlier, the study did not define the type of arthritis in subjects. However, the National Institutes of Health (NIH, Bethesda, Maryland) estimates the prevalence of OA is about 10 times that of RA. (47) According to these estimates, our data most likely predominantly reflect OA. Since some prior studies suggest that the risk of CHD and CHD-related events is lower in OA than RA, our data pool may have been less likely to capture a strong association between arthritis and CHD. Whether RA was a risk factor for CHD in our population cannot be independently determined. Finally, the study gathered data about arthritis by self-report, and such data might be expected to include nonspecific joint complaints, and, therefore, potentially overestimate the presence of arthritis. On the other hand, many subjects may not consult a physician for mild joint pains, and as a consequence may not be able to affirmatively answer questions regarding a physician diagnosis of arthritis. While the validity of using self-reports to estimate true prevalence of arthritis is unknown in this cohort, and the lack of association between arthritis and incident CHD could be due to a type I error related to misclassification of arthritis, both Bombard and associates and the CDC have shown that self-reported data can be reliably used to study the prevalence of arthritis. (1,2,48) Patient self-reporting of a diagnosis of arthritis received from a physician, as in our study, was particularly reliable in the Bombard study. (48) In addition, NHANES III also identified comorbid medical conditions mainly by subjects' self-report rather than by physical examination. NHANES suggests self-reported measures can be quite reliable, based on studies conducted on other diseases. For example, sensitivity and specificity of self-reported hypertension in NHANES III has been assessed, and deemed valid for use in surveillance for the U.S. population. (49)
Our study also has many strengths. This is a population-based study with large numbers and good compliance rates. The follow-up period of 8 years is relatively long. This is a unique, stable population of elderly Japanese-American males with a very low out-migration rate. Surveillance for the outcome (incident CHD) is essentially complete, since this is an island population and subjects do not generally leave the area for medical care.
Our study results suggest that arthritis may not be associated with cardiovascular risk factors in elderly Japanese-American males. Furthermore, arthritis may not be a risk factor for incident CHD in this cohort. Although these observations probably relate to OA, our data do not permit formal stratification. The differences between our results and those observed in other populations may provide insight into the mechanisms through which arthritis is, or is not, associated with CHD.
This project was supported by contract number N01-HC-05102 from the National Heart, Lung, and Blood Institute and contract number N01-AG-4-2149 from the National Institute on Aging, and grant number U01-HL-56274 from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD; the John A. Hartford Center of Excellence in Geriatrics, University of Hawaii; and the Donald W. Reynolds Foundation "Comprehensive Programs to Strengthen Physicians' Training in Geriatrics" grant, Department of Geriatric Medicine, John A. Burns School of Medicine, University of Hawaii.
(1.) Centers for Disease Control and Prevention (CDC). Arthritis prevalence and activity limitations United States. MMWR Morb Mortal Wkly Rep. 1994 Jun 24;43(24):433-8.
(2.) Centers for Disease Control and Prevention, Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2001 Feb 23;50(7):120-5. Erratum in: MMWR Morb Mortal Wkly Rep 2001 Mar 2;50(8):149.
(3.) Goodson N. Coronary artery disease and rheumatoid arthritis. Curr Opin Rheumatol. 2002 Mar;14(2):115-20.
(4.) del Rincon ID, Williams K, Stern MP, et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2001 Dec;44(12):2737-45.
(5.) Wong M, Toh L, Wilson A, et al. Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation. Arthritis Rheum. 2003 Jan;48(1):81-9.
(6.) Bjornadal L, Baecklund E, Yin L, et al, Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95. J Rheumatol. 2002 May;29(5):906-12.
(7.) Jacobsson LT, Turesson C, Hanson RL, et al. Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indian. Arthritis Rheum. 2001 May;44(5):1170-6.
(8.) Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003 Mar 11;107(9):1303-7.
(9.) Wolfe F, Freundlich B, Straus WL. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol. 2003 Jan;30(1):36-40.
(10.) Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 1998 Aug;41(8):1343-55.
(11.) Singh G, Miller JD, Lee FH, et al. Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: Data from the Third National Health and Nutrition Examination Survey. Am J Manag Care. 2002 Oct;8(15 Suppl):S383-91.
(12.) Haara MM, Manninen P, Kroger H, et al. Osteoarthritis of finger joints in Finns aged 30 or over: prevalence, determinants, and association with mortality. Ann Rheum Dis. 2003 Feb;62(2):151-8.
(13.) Philbin EF, Groff GD, Ries MD, Miller TE. Cardiovascular fitness and health in patients with end-stage osteoarthritis. Arthritis Rheum. 1995 Jun;38(6):799-805.
(14.) Philbin EF, Ries MD, Groff GD, et al. Osteoarthritis as a determinant of an adverse coronary heart disease risk profile. J Cardiovasc Risk. 1996 Dec;3(6):529-33.
(15.) Worth RM, Kagan A. Ascertainment of men of Japanese ancestry in Hawaii through World War II Selective Service registration. J Chronic Dis. 1970 Nov;23(5):389-97.
(16.) Heilbrun LK, Kagan A, Nomura A, Wasnich RD. The origins of epidemiology studies of heart disease, cancer and osteoporosis among Hawaii Japanese, Hawaii Med J. 1985 Aug;44(8):294-6.
(17.) Ceria CD, Masaki KH, Rodriguez BL, et al. The relationship of psychosocial factors to total mortality among older Japanese-American men: The Honolulu Heart Program. J Am Geriatr Soc. 2001 Jun;49(6):725-31.
(18.) Burchfiel CM, Curb JD, Arakaki R, et al. Physical activity and incidence of diabetes: the Honolulu Heart Program. Ann Epidemiol. 1996 Nov;6(6):490-7.
(19.) Rodriguez BL, Abbott RD, Fujimoto W, et al. The American Diabetes Association and World Health Organization classifications for diabetes: their impact on diabetes prevalence and total and cardiovascular disease mortality in elderly Japanese American men. Diabetes Care. 2002 Jun;25(6):951-5.
(20.) Burchfiel CM, Abbott RD, Sharp DS, et al. Distribution and correlates of lipids and lipoproteins in elderly Japanese-American men: the Honolulu Heart Program. Arterioscler Thromb Vasc Biol. 1996 Nov;16(11):1356-64.
(21.) Fried LP, Borhani NO, Enright P, et al. The cardiovascular health study: design and rationale. Ann Epidemiol. 1991 Feb;1(3):263-76.
(22.) White L, Petrovitch H, Ross GW, et al. Prevalence of dementia in older Japanese-American men in Hawaii: The HonoluluAsia Aging Study. JAMA. 1996 Sep 25;276(12):955-60.
(23.) Hurst W. The Heart, Arteries and Veins. (10th ed). New York: McGraw-Hill, 2002.
(24.) Syme SL, Marmot MG, Kagan A, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: introduction. Am J Epidemiol. 1975 Dec;102(6):477-80.
(25.) Erb N, Pace AV, Douglas KM, et al. Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol. 2004;33(5):293-9.
(26.) Wolfe F, Freundlich B, Straus WL. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis, J Rheumatol. 2003 Jan;30(1):36-40.
(27.) Rasch EK, Hirsch R, Paulose-Ram R, Hochberg MC. Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification. Arthritis Rheum. 2003 Apr;48(4):917-26.
(28.) Braun J, Bollow M, Remlinger G, et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum. 1998 Jan;41(1):58-67.
(29.) Manzi S, Wasko MC. Inflammation-mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis. 2000 May;59(5):321-5.
(30.) Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus, N Engl J Med. 2003 Dec 18;349(25):2399 406.
(31.) Asanuma Y, Oeser A, Shintani AK, et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus, N Engl J Med. 2003 Dec 18;349(25):2407-15.
(32.) Martel-Pelletier J, Alaaeddine N, Pelletier JP. Cytokines and their role in the pathophysiology of osteoarthritis, Front Biosci. 1999 Oct 15;4:D694-703.
(33.) Goldring MB. The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models, Connect Tissue Res. 1999;40(1):1-11.
(34.) Spector TD, Hart DJ, Nandra D, et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum. 1997 Apr;40(4):723-7.
(35.) Manninen P, Riihimaki H, Heliovaara M, Makela P. Overweight, gender and knee osteoarthritis. Int J Obes Relat Metab Disord. 1996 Jun;20(6):595-7.
(36.) Felson DT, Zhang Y, Hannan MT, et al. Risk factors for incident radiographic knee osteoarthritis in the elderly. Arthritis Rheum. 1997 Apr;40(4):728-33.
(37.) Centers for Disease Control and Prevention. Healthy weight, overweight, and obesity among U.S. adults. National Health and Nutrition Examination Survey July 2003. Available at: http://www.cdc.gov/nchs/data/nhanes/databriefs/adultweight.pdf. Accessed April 21, 2006.
(38.) Rashid MN, Fuentes F, Touchon RC, Wehner PS. Obesity and the risk for cardiovascular disease, Prev Cardiol. 2003 Winter;6(1):42-7.
(39.) Kannel WB, Wilson PW, Nam BH, D'Agostino RB. Risk stratification of obesity as a coronary risk factor. Am J Cardiol. 2002 Oct 1;90(7):697-701.
(40.) Gregg EW, Cauley JA, Stone K, et al. Relationship of changes in physical activity and mortality among older women. JAMA. 2003 May 14;289(18):2379-86.
(41.) Sandvik L, Erikssen J, Thaulow E, et al. Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men, N Engl J Med. 1993 Feb 25;328(8):533-7.
(42.) Arraiz GA, Wigle DT, Mao Y. Risk assessment of physical activity and physical fitness in the Canada Health Survey Mortality Follow-Up Study. J Clin Epidemiol. 1992 Apr;45(4):419-28.
(43.) Sherman SE, D'Agostino RB, Cobb JL, Kannel WB. Physical activity and mortality in women in the Framingham Heart Study. Am Heart J. 1994 Nov;128(5):879-84.
(44.) Williamson DF, Madans J, Anda RF, et al. Recreational physical activity and ten-year weight changes in at US national cohort. Int J Obes Relat Metab Disord. 1993 May;17(5):279 86.
(45.) Voorrips LE, Meijers JH, Sol P, et al. History of body weight and physical activity of elderly women differing in current physical activity. Int J Obes Relat Metab Disord. 1992 Mar;16(3):199-205.
(46.) Graham DJ, Campen D, Hui R, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet. 2005 Feb 5-11;365(9458):475-81.
(47.) National Institute of Arthritis and Musculoskeletal and Skin Diseases. Question and answers about arthritis and rheumatic diseases. Available at: http://www.niams.nih.gov/hi/topics/arthritis/artrheu.htm. Accessed April 21, 2006.
(48.) Bombard JM, Powell KE, Martin LM, et al. Validity and reliability of self-reported arthritis: Georgia senior centers, 2000-2001. Am J Prev Med. 2005 Apr;28(3):251-8.
(49.) Vargas CM, Burt VL, Gillum RF, Pamuk ER. Validity of self-reported hypertension in the National Health and Nutrition Examination Survey III, 1988-1991. Prev Med. 1997 Sep-Oct;26(5 Pt 1):678-85.
Mitsumasa Kishimoto, M.D., Ph.D., is from the Division of Rheumatology, NYU School of Medicine, NYU Hospital for Joint Diseases, New York, New York, and the Department of Rheumatology, Kameda Medical Center, Kamogawa, Chiba, Japan. Jeffrey Greenberg, M.D., M.P.H., is from the Division of Rheumatology, NYU School of Medicine, NYU Hospital for Joint Diseases, New York, New York. Ryan Lee, B.S., is from the Department of Geriatric Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii. Kamal H. Masaki, M.D., Patricia L. Blanchette, M.D., M.P.H., and J. David Curb, M.D., are from the Department of Geriatric Medicine, John A. Burns School of Medicine, University of Hawaii, and the Honolulu Heart Program, Kuakini Medical Center, Honolulu, Hawaii. Randi Chen, M.S., and Beatriz L. Rodriguez, M.D., Ph.D., are from the Honolulu Heart Program, Kuakini Medical Center, Honolulu, Hawaii. Michael H. Pillinger, M.D., is from the Division of Rheumatology, NYU School of Medicine, NYU Hospital for Joint Diseases, New York, New York.
Correspondence: Mitsumasa Kishimoto, M.D., Kameda Medical Center, 929 Higashicho Kamogawa city, Chiba, Japan 296-8602; email@example.com.
Kishimoto M, Greenberg J, Lee R, Masaki KH, Chen R, Rodriguez BL, Blanchette P, Pillinger MH, Curb JD. Arthritis as a risk factor for incident coronary heart disease in elderly Japanese-American males: The Honolulu Heart Program. Bull NYU Hosp Jt Dis. 2009;67(2):230-5.
Table 1 Age-Adjusted Means of Cardiovascular Risk Factors by Current Arthritis Status Risk Factors No Arthritis Arthritis P Age (years) 77.8 77.5 0.195 Body Mass Index (kg/[m.sup.2]) 23.3 23.8 0.003 Physical Activity Index 31.0 30.9 0.627 Total Cholesterol (mg/dL) 190.6 190.0 0.720 HDL Cholesterol (mg/dL) 51.8 50.5 0.083 Hypertension 73.3% 75.2% 0.414 Diabetes Mellitus 26.0% 22.5% 0.134 Current Smoking 8.0% 5.2% 0.579 Fibrinogen (mg/dL) 303.9 308.1 0.218 Alcohol Intake (ounces/month) 19.5 19.1 0.848 ASA or NSAID Use, or Both 21.4% 39.6% < 0.001 Chi-square tests used for categorical variables. ANOVA used for continuous variables. Means reported for all continuous variables. Table 2 Rates of 8-year Incident Coronary Heart Disease by Current Arthritis Status in Subjects Free of CHD at Baseline No Current Current Arthritis Arthritis Number of Participants 2374 403 Total Number of Cases 232 (9.8%) 47 (11.7%) of Incident CHD Over 8 Years of Follow-Up Unadjusted Rates of Incident 17.6 20.8 CHD per 1000 Person Years Age-Adjusted Rates of Incident 18.0 20.5 CHD per 1000 Person Years Table 3 Cox Proportional Hazard Models for Association Between Current Arthritis and 8-Year Incident CHD Relative Risk for Cox Model * Current Arthritis 95% CI P 1 1.23 0.90-1.68 0.21 2 1.12 0.79-1.58 0.53 3 1.06 0.74-1.51 0.76 * Model 1, Adjusted for age; Model 2, Adjusted for age, BMI, physical activity index, hypertension, diabetes mellitus, HDL cholesterol, total cholesterol, smoking status; Model 3, Adjusted for age, BMI, physical activity index, hypertension, diabetes mellitus, HDL cholesterol, total cholesterol, smoking status, fibrinogen, alcohol intake, and ASA and/or NSAID use. Table 4 Cox Proportional Hazard Models for Association Between Current Arthritis and 8-Year Incident CHD, Excluding Those with Dementia and Cognitive Impairment Relative Risk for Cox Model * Current Arthritis 95% CI P 1 1.32 0.95-1.84 0.10 2 1.25 0.87-1.80 0.22 3 1.18 0.82-1.71 0.38 * Model 1, Adjusted for age; Model 2, Adjusted for age, BMI, physical activity index, hypertension, diabetes mellitus, HDL cholesterol, total cholesterol, smoking status; Model 3, Adjusted for age, BMI, physical activity index, hypertension, diabetes mellitus, HDL cholesterol, total cholesterol, smoking status, fibrinogen, alcohol intake, ASA and/or NSAID use.
|Gale Copyright:||Copyright 2009 Gale, Cengage Learning. All rights reserved.|